why is it ridiculous? it's a $6.5bn valuation with a test molecule.... nothing proven. why is $5bn not too expensive, let alone $1bn
it's you who is being stupid.... you have just been told it's 3 years before data!!
and a real possibility of fundraising....and you want it to be valued at $6.5bn plus????
and this trial is longer and more expensive... it's so obvious a sell it's ridiculous. will see the air come out of this
this is crazzzzy..... will go back to $200 so quickly
very rare to be able to buy top notch company.
it's still trading at 15 times this year's earnings...
this is $15 stock if it manages to survive
that is seriously your answer??? LOL
and you are telling me to get a clue????????
Thats madness.... VRX has bought a dud.
$350bn- $1tn market cap on cure for cancers.